Elevation Oncology
Robert C. Yang has over 10 years of experience serving as counsel to public companies during stages of substantial growth, mainly in the biotechnology industry. Prior to joining Elevation Oncology, he was Executive Director and Assistant General Counsel at REGENXBIO, a leading gene therapy company, where he advised on several major capital markets and corporate development transactions in addition to legal matters across all business functions. Earlier in his career, Robert was an associate at the international law firm of Gibson, Dunn & Crutcher, where he practiced in the areas of capital markets, securities regulation and corporate governance. He received his J.D. with honors from New York University School of Law and his B.S. in Economics from Duke University.
This person is not in any teams
This person is not in any offices
Elevation Oncology
Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. They make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease.